Autologous CAR-T Cells Targeting B7-H3 in PDAC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Autologous CAR-T Cells Targeting B7-H3 in PDAC — Stella

Home/Pancreas Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Pancreas Cancer trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Key details

Phase

Early testing

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

M.D. Anderson Cancer Center

Enrollment target

~27 participants

Started

July 2024

Primary completion

April 2028

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years and older

Last updated March 2026